BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23453090)

  • 1. INtensive versus standard ambulatory blood pressure lowering to prevent functional DeclINe in the ElderlY (INFINITY).
    White WB; Marfatia R; Schmidt J; Wakefield DB; Kaplan RF; Bohannon RW; Hall CB; Guttmann CR; Moscufo N; Fellows D; Wolfson L
    Am Heart J; 2013 Mar; 165(3):258-265.e1. PubMed ID: 23453090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Intensive Versus Standard Ambulatory Blood Pressure Control on Cerebrovascular Outcomes in Older People (INFINITY).
    White WB; Wakefield DB; Moscufo N; Guttmann CRG; Kaplan RF; Bohannon RW; Fellows D; Hall CB; Wolfson L
    Circulation; 2019 Nov; 140(20):1626-1635. PubMed ID: 31607143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid buildup of brain white matter hyperintensities over 4 years linked to ambulatory blood pressure, mobility, cognition, and depression in old persons.
    Wolfson L; Wakefield DB; Moscufo N; Kaplan RF; Hall CB; Schmidt JA; Guttmann CR; White WB
    J Gerontol A Biol Sci Med Sci; 2013 Nov; 68(11):1387-94. PubMed ID: 23766429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships among clinic, home, and ambulatory blood pressures with small vessel disease of the brain and functional status in older people with hypertension.
    White WB; Jalil F; Wakefield DB; Kaplan RF; Bohannon RW; Hall CB; Moscufo N; Fellows D; Guttmann CRG; Wolfson L
    Am Heart J; 2018 Nov; 205():21-30. PubMed ID: 30145340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
    Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of ambulatory blood pressure monitoring compared with clinic and home blood pressure measures in evaluating moderate versus intensive treatment of hypertension with amlodipine/valsartan for patients uncontrolled on angiotensin receptor blocker monotherapy.
    Giles TD; Oparil S; Ofili EO; Pitt B; Purkayastha D; Hilkert R; Samuel R; Sowers JR
    Blood Press Monit; 2011 Apr; 16(2):87-95. PubMed ID: 21386706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral White Matter Hyperintensities, Kidney Function Decline, and Recurrent Stroke After Intensive Blood Pressure Lowering: Results From the Secondary Prevention of Small Subcortical Strokes ( SPS 3) Trial.
    Ikeme JC; Pergola PE; Scherzer R; Shlipak MG; Catanese L; McClure LA; Benavente OR; Peralta CA
    J Am Heart Assoc; 2019 Feb; 8(3):e010091. PubMed ID: 30686103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of night-time blood pressure on cerebral white matter hyperintensity in elderly hypertensive patients.
    Kokubo M; Shimizu A; Mitsui T; Miyagi M; Nomoto K; Murohara T; Toba K; Sakurai T
    Geriatr Gerontol Int; 2015 Dec; 15 Suppl 1():59-65. PubMed ID: 26671159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Average daily blood pressure, not office blood pressure, is associated with progression of cerebrovascular disease and cognitive decline in older people.
    White WB; Wolfson L; Wakefield DB; Hall CB; Campbell P; Moscufo N; Schmidt J; Kaplan RF; Pearlson G; Guttmann CR
    Circulation; 2011 Nov; 124(21):2312-9. PubMed ID: 22105196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. White matter hyperintensities mediate the association of nocturnal blood pressure with cognition.
    Chesebro AG; Melgarejo JD; Leendertz R; Igwe KC; Lao PJ; Laing KK; Rizvi B; Budge M; Meier IB; Calmon G; Lee JH; Maestre GE; Brickman AM
    Neurology; 2020 Apr; 94(17):e1803-e1810. PubMed ID: 32295824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensive blood pressure lowering increases cerebral blood flow in older subjects with hypertension.
    Tryambake D; He J; Firbank MJ; O'Brien JT; Blamire AM; Ford GA
    Hypertension; 2013 Jun; 61(6):1309-15. PubMed ID: 23529166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
    Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
    Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the efficacy and duration of action of candesartan cilexetil and losartan as assessed by clinic and ambulatory blood pressure after a missed dose, in truly hypertensive patients: a placebo-controlled, forced titration study. Candesartan/Losartan study investigators.
    Lacourcière Y; Asmar R
    Am J Hypertens; 1999 Dec; 12(12 Pt 1-2):1181-7. PubMed ID: 10619580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does white coat hypertension require treatment over age 80?: Results of the hypertension in the very elderly trial ambulatory blood pressure side project.
    Bulpitt CJ; Beckett N; Peters R; Staessen JA; Wang JG; Comsa M; Fagard RH; Dumitrascu D; Gergova V; Antikainen RL; Cheek E; Rajkumar C
    Hypertension; 2013 Jan; 61(1):89-94. PubMed ID: 23172934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Intensive Versus Standard Clinic-Based Hypertension Management on Ambulatory Blood Pressure: Results From the SPRINT (Systolic Blood Pressure Intervention Trial) Ambulatory Blood Pressure Study.
    Drawz PE; Pajewski NM; Bates JT; Bello NA; Cushman WC; Dwyer JP; Fine LJ; Goff DC; Haley WE; Krousel-Wood M; McWilliams A; Rifkin DE; Slinin Y; Taylor A; Townsend R; Wall B; Wright JT; Rahman M
    Hypertension; 2017 Jan; 69(1):42-50. PubMed ID: 27849563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disproportional decrease in office blood pressure compared with 24-hour ambulatory blood pressure with antihypertensive treatment: dependency on pretreatment blood pressure levels.
    Schmieder RE; Schmidt ST; Riemer T; Dechend R; Hagedorn I; Senges J; Messerli FH; Zeymer U
    Hypertension; 2014 Nov; 64(5):1067-72. PubMed ID: 25259741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial.
    Lithell H; Hansson L; Skoog I; Elmfeldt D; Hofman A; Olofsson B; Trenkwalder P; Zanchetti A;
    J Hypertens; 2003 May; 21(5):875-86. PubMed ID: 12714861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicenter, randomized, double-blind comparison of the efficacy and safety of irbesartan and enalapril in adults with mild to moderate essential hypertension, as assessed by ambulatory blood pressure monitoring: the MAPAVEL Study (Monitorización Ambulatoria Presión Arterial APROVEL).
    Coca A; Calvo C; García-Puig J; Gil-Extremera B; Aguilera MT; de la Sierra A; Martín-Hidalgo A; Marín R;
    Clin Ther; 2002 Jan; 24(1):126-38. PubMed ID: 11833827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Febuxostat on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension: A Phase 2 Randomized Placebo-Controlled Study.
    Gunawardhana L; McLean L; Punzi HA; Hunt B; Palmer RN; Whelton A; Feig DI
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29102979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excessive lowering of blood pressure is not beneficial for progression of brain white matter hyperintensive and cognitive impairment in elderly hypertensive patients: 4-year follow-up study.
    Peng J; Lu F; Wang Z; Zhong M; Sun L; Hu N; Liu Z; Zhang W
    J Am Med Dir Assoc; 2014 Dec; 15(12):904-10. PubMed ID: 25239015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.